Read more
14:50 · 19 October 2023

BREAKING: EU approves Pfizer's prposed acqusition of Seagen!

-
-
Open account Download free app
-
-
Open account Download free app

Pfizer's (PFE.US) $43 billion Seagen (SGEN.US) deal wins unconditional EU approval. As it was concluded by European lawmakers, deal wouldn't raise competition concerns or higher prices for oncology drugs. 

Source: xStation5 

4 March 2026, 07:48

Trump’s plan for Strait of Hormuz fails to stop gains in oil price, as investors pause European sell off

3 March 2026, 18:05

Paramount Skydance shares under pressure after S&P warning

3 March 2026, 17:33

Broadcom as the Last of the Big Tech. What Can Markets Expect from the Earnings?

3 March 2026, 16:40

Nvidia Faces New H200 Limits in China

This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.

Join over 2 Million investors from around the world